{
  "Variants Include": [
    {
      "Gene": "LRRK2",
      "variants": [
        {
          "HGVS": "NM_004946.3:c.6056A>G",
          "cDNA Change": {
            "transcript": "NM_004946.3",
            "ref": "A",
            "alt": "G",
            "position": "6056"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "S",
            "position": "2019"
          },
          "Description in input context": "G2019S variant in LRRK2"
        },
        {
          "HGVS": "NM_004946.3:c.5854G>A",
          "cDNA Change": {
            "transcript": "NM_004946.3",
            "ref": "G",
            "alt": "A",
            "position": "5854"
          },
          "Protein Change": {
            "ref": "G",
            "alt": "R",
            "position": "1951"
          },
          "Description in input context": "R1951G variant in LRRK2"
        }
      ]
    },
    {
      "Gene": "GBA",
      "variants": [
        {
          "HGVS": "NM_000380.3:c.1099A>G",
          "cDNA Change": {
            "transcript": "NM_000380.3",
            "ref": "A",
            "alt": "G",
            "position": "1099"
          },
          "Protein Change": {
            "ref": "N",
            "alt": "D",
            "position": "370"
          },
          "Description in input context": "N370S variant in GBA"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson's disease; Gaucher's disease",
    "MONDO": "MONDO:0005257; MONDO:0005139"
  },
  "Experiment Method": [
    {
      "Assay Method": "Western Blot",
      "Material used": {
        "Material Source": "Cell line",
        "Material Name": "HEK293",
        "Description": "HEK293 cells expressing wild-type or mutant LRRK2 were used."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_004946.3:c.6056A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "gain-of-function",
          "Result Description": "Increased phosphorylation of LRRK2 at S935 in the G2019S variant."
        },
        {
          "Variant": "NM_004946.3:c.5854G>A",
          "Conclusion": "Abnormal",
          "Molecular Effect": "partial loss-of-function",
          "Result Description": "Reduced LRRK2 kinase activity in the R1951G variant."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "Yes",
        "Description": "Three independent experiments were performed."
      },
      "Technical replicates": {
        "Technical replicates": "Yes",
        "Description": "Each sample was run in triplicate."
      },
      "Basic positive control": {
        "Basic positive control": "Yes",
        "Description": "Wild-type LRRK2 was used as a positive control."
      },
      "Basic negative control": {
        "Basic negative control": "Yes",
        "Description": "Empty vector was used as a negative control."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "Yes",
        "Counts": "2"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "ANOVA was used for statistical analysis."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Phosphorylation levels within 10% of wild-type.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Phosphorylation levels exceeding 30% of wild-type.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Immunohistochemistry",
      "Material used": {
        "Material Source": "Postmortem brain tissue",
        "Material Name": "Parkinson's disease patients",
        "Description": "Postmortem brain tissue from Parkinson's disease patients was analyzed."
      },
      "Readout type": "Qualitative",
      "Readout description": [
        {
          "Variant": "NM_000380.3:c.1099A>G",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Reduced GBA enzyme activity in N370S variant carriers."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "No",
        "Description": "N.D."
      },
      "Technical replicates": {
        "Technical replicates": "No",
        "Description": "N.D."
      },
      "Basic positive control": {
        "Basic positive control": "No",
        "Description": "N.D."
      },
      "Basic negative control": {
        "Basic negative控制": "No",
        "Description": "N.D."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "No",
        "Counts": "0"
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "No",
        "Counts": "0"
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "N.D."
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "N.D."
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}